BANK OF AMERICA CORP /DE/ - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$216,300
+14.2%
22,461
+6.7%
0.00%
Q2 2023$189,423
+5.5%
21,047
-7.8%
0.00%
Q1 2023$179,475
+48.8%
22,834
+27.9%
0.00%
Q4 2022$120,652
+43.6%
17,848
+209.5%
0.00%
Q3 2022$84,000
+9.1%
5,766
-26.4%
0.00%
Q2 2022$77,000
-92.5%
7,837
-88.8%
0.00%
Q1 2022$1,033,000
+15.9%
70,068
+4.0%
0.00%
Q4 2021$891,000
+284.1%
67,351
+408.4%
0.00%
Q3 2021$232,000
-16.8%
13,248
+13.4%
0.00%
Q2 2021$279,000
-43.4%
11,687
-39.1%
0.00%
Q1 2021$493,000
+97.2%
19,196
+45.6%
0.00%
Q4 2020$250,000
+32.3%
13,187
-11.9%
0.00%
Q3 2020$189,000
-18.2%
14,965
-21.4%
0.00%
Q2 2020$231,000
+51.0%
19,037
-4.9%
0.00%
Q1 2020$153,000
+96.2%
20,023
+359.2%
0.00%
Q4 2019$78,000
-13.3%
4,360
-43.2%
0.00%
Q3 2019$90,000
-20.4%
7,675
+50.3%
0.00%
Q2 2019$113,000
-31.1%
5,106
-10.9%
0.00%
Q1 2019$164,000
+88.5%
5,729
+30.4%
0.00%
Q4 2018$87,000
+1640.0%
4,394
+1693.5%
0.00%
Q3 2018$5,0002450.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders